Journal of Molecular Histology

, Volume 35, Issue 8–9, pp 823–827 | Cite as

Teratogenicity of retinoic acid and its effects on TGF-β2 expression in the developing cerebral cortex of the rat

  • Neriman Çolakoğlu
  • Aysel Kükner


Vitamin A metabolites are potent teratogens in a wide variety of species, including man. Transforming growth factor betas (TGF-βs) are involved in several mammalian prenatal developmental processes. The aim of this study was to determine the effects of exogenous and excessive all-trans retinoic acid on TGFβ2 expression in the developing cerebral cortex of the rat. Many of the malformations including exencephaly, exophtalmus, abdominal wall defects, extremity reduction defects observed in this study were dependent on the time of administration of retinoic acid. TGF-β2 was diversely expressed, as revealed immunohistochemically, in the cerebral cortex and plexus choroideus. The diversity depended on the gestational day and the was affected by the administration of retinoic acid. In the 15-day-old fetus from mothers who had been fed by gavage a single dose of 60 mg/kg body weight of all-trans retinoic acid on the 8th day of gestation, TGF-β2 immunoreactivity in the brain was decreased. However, by the 18th day of gestation, TGF-β2 expression increased. The expression of TGF-β2 in fetuses whose mothers had been given all-trans retinoic acid after the neurulation period (on day 12 of gestation) was generally similar to that in a control group. We conclude that all-trans retinoic acid leads to severe congenital malformations if administered before neurulation whereas if given after neurulation, it is not so teratogenic. Further, retinoic acid has a variable effect on the expression of TGF-β2.


Single Dose Cerebral Cortex Abdominal Wall Retinoic Acid Developmental Process 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Akhurst, RJ, FitzPatrick, DR, Gatherer, D, Lehnert, SA, Millan, FA 1990Transforming growth factor betas in mammalian embryogenesisProg Growth Factor Res2153168Google Scholar
  2. Chescheir, NC, Seeds, JW 1988Spontaneous resolution of hypofibrinogenemia associated with death of a twin in utero: A case reportAm J Obstet Gynecol15911831184Google Scholar
  3. Danielpour, D, Kim, KY, Winokur, TS, Sporn, MB 1991Differential regulation of the expression of transforming growth factor-\betas 1 and 2 by retinoic acid, epidermal growth factor and dexamethasone in NRK-49F and A549 cellsJ Cell Physiol148235244Google Scholar
  4. Dencker, L, d’Argy, R, Danielsson, BRG, Ghantous, H, Sperber, GO 1987Saturable accumulation of retinoic acid in neural and neural crest derived cells in early embryonic developmentDev Pharmacol Ther10212223Google Scholar
  5. Dobbertin, A, Gervais, A, Glowinski, J, Mallat, M 2000Activation of ionotropic glutamate receptors reduces the production of transforming growth factor-beta2 by developing neuronsEur J NeuroSci1245894593Google Scholar
  6. Gudas, LJ 1994Retinoids and vertebrate developmentJ Biol Chem2691539915402Google Scholar
  7. Hansen, LA, Pearl, GS 1985Isotretionin teratogenicityActa Neuropathol65335337Google Scholar
  8. Hao, AJ, Dheen, ST, Ling, EA 2001Induction of cytokine expression in the brain macrophages/amoeboid microglia of the fetal rat exposed to a teratogenNeuroreport1213911397Google Scholar
  9. Hart, RC, Mccue, PA, Ragland, WL, Winn, KJ, Unger, RE 1990Avian model for 13 cis retinoic acid embryopathy: Demonstration of neural crest related defectsTeratology41463472Google Scholar
  10. Heine, UI, Munoz, EF, Flanders, KC, Ellingsworth, LR, Lam, HY, Thompson, NL, Roberts, AB, Sporn, MB 1987Role of transforming growth factor-\beta in the development of the mouse embryoJ␣Cell Biol10528612876Google Scholar
  11. Holson, RR, Gazzara, RA, Ferguson, SA, Adams, J 1997A behavioral and neuroanatomical investigation of the lethality caused by gestational day 11–13 cis retinoic acid exposureNeurotoxicol Teratol19347353Google Scholar
  12. Ivnitsky, I, Torchinsky, A, Savion, S, Shepshelovich, J, Orenstein, H, Fein, A 2001TGF beta2 in embryos with inborn anomalies: Effect of maternal immunopotentiationAm J Reprod Immunol454151Google Scholar
  13. Jakowlew, SB, Cubert, J, Danielpour, D, Sporn, MB, Roberts, AB 1992Differential regulation of expression of TGF-\beta mRNA s by growth factors and retinoic acid in the chicken embryo condrocytes, myocytes and fibroblastsJ Cell Physiol150377385Google Scholar
  14. Kochar, DM 1967Teratogenic activity of retinoic acidActa Pathol Microbiol70398404Google Scholar
  15. Kochar, DM, Penner, JD, Tellone, CI 1984Comparative teratogenic activities of two retinoids: Effects on palate and limb developmentTeratog Carcinog Mutagen4377387Google Scholar
  16. Kraft, JC, Löfberg, B, Chahoud, I, Bochert, G, Nau, H 1989Teratogenicity and placental transfer of all-trans, 13-cis-4-oxo-all-trans- and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in miceToxicol Appl Pharmacol100162176Google Scholar
  17. Krieglstein, K, Strelau, J, Schober, A, Sullivan, A, Unsicker, K 2002TGF-beta and the regulation of neuron survival and deathJ Physiol Paris962530Google Scholar
  18. Mahmood, R, Flanders, KC, Morris-Kay, GM 1992Interactions betweeen retinoids and TGF-\betas in mouse morphogenesisDevelopment1156774Google Scholar
  19. Nau, H 1990Correlation of transplacental and maternal pharmacokinetics of retinoids during organogenesis with teratogenicityMethods Enzymol190437448Google Scholar
  20. Nau, H 1993Retinoid teratogenesis: Toxicokinetics and structure-specificityArc Toxicol16118127Google Scholar
  21. Noy, N 2000Retinoid binding proteins: Mediators of retinoid actionBiochem J348481495Google Scholar
  22. Ostlund, E, Tally, M, Fried, G 2002Transforming growth factor-beta 1 in fetal serum correlates with insulin-like growth factor-I and fetal growthObstet Gynecol100567573Google Scholar
  23. Pauken, CM, LaBorde, JB, Bolon, B 1999Retinoic acid acts during periimplantational development to alter axial and brain formationAnat Embryo200645655Google Scholar
  24. Pelton, RW, Saxena, B, Jones, M, Moses, HL, Gold, LI 1991Immunohistochemical localization of TGF-\beta1, TGF-\beta2 and TGF-\beta3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic developmentJ Cell Biol11510911105Google Scholar
  25. Pena, JDO, Taylor, AW, Ricard, CS, Vidal, I, Hernandez, MR 1999Transforming growth factor β isoforms in human optic nerve headsBr J Ophthalmol83209218Google Scholar
  26. Rosa, WF, Wilk, AL, Kelsey, FO 1986Teratogen update: Vitamin A congenersTeratology33355364Google Scholar
  27. Rutlege, JC, Shourbaji, AG, Huges, LA, Polifka, JE, Cruz, YP, Bishop, JP, Generoso, WM 1994Limb and lower body duplications induced by retinoic acid in miceProc Natl Acad Sci USA9154365440Google Scholar
  28. Satre, MA, Penner, JD, Kochar, DM 1989Pharmacokinetic assesment of teratologically effective concentrations of an endogenous retinoic acid metaboliteTeratology39341348Google Scholar
  29. Slager, HG, Lawson, KA, Van-Raaij, AJM, Delaat, SW, Mummery, CL 1991Differential localization of TGF-\beta2 in mouse preimplantation and early postimplantation developmentDev Biol145205218Google Scholar
  30. Strömland, K, Miller, M, Cook, C 1991Occular teratologySurv Ophthalmol35429446Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Neriman Çolakoğlu
    • 1
  • Aysel Kükner
    • 1
  1. 1.Medical Faculty, Histology and Embryology DepartmentFirat UniversityElazigTurkey

Personalised recommendations